Display Settings:

Format

Send to:

Choose Destination
See comment in PubMed Commons below
Semin Cell Dev Biol. 2005 Aug-Oct;16(4-5):523-30. Epub 2005 Apr 22.

The HIF pathway in cancer.

Author information

  • 1Renal Section, Hammersmith Campus, Imperial College London, Du Cane Road, London W12 0NN, UK. p.maxwell@imperial.ac.uk

Abstract

The transcription factor hypoxia-inducible factor-1 (HIF) is commonly activated in cancer. This has major effects on gene expression, and is important in tumor angiogenesis. Besides being activated by low oxygen, genetic events in cancer contribute to activating HIF. Most striking is that loss of function of the VHL tumour suppressor protein results in constitutive activation of the HIF pathway. An important aim is to define the contribution of HIF activation to the evolution of different cancers, and its potential as a therapeutic target.

PMID:
16144689
[PubMed - indexed for MEDLINE]
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for Elsevier Science
    Loading ...
    Write to the Help Desk